IRIS Institutional Research Information System - OPENBS Open Archive UniBS

PILOTTO, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.956
AS - Asia 5.843
EU - Europa 3.727
SA - Sud America 1.443
AF - Africa 156
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 4
Totale 20.139
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.738
SG - Singapore 2.352
CN - Cina 1.580
BR - Brasile 1.203
IT - Italia 839
HK - Hong Kong 692
DE - Germania 578
FR - Francia 512
VN - Vietnam 430
UA - Ucraina 412
FI - Finlandia 306
GB - Regno Unito 272
RU - Federazione Russa 217
TR - Turchia 196
IE - Irlanda 171
IN - India 131
BD - Bangladesh 124
CA - Canada 91
AR - Argentina 84
MX - Messico 81
NL - Olanda 75
CZ - Repubblica Ceca 58
PL - Polonia 55
ZA - Sudafrica 53
AT - Austria 50
ID - Indonesia 50
ES - Italia 48
IQ - Iraq 47
JP - Giappone 45
SE - Svezia 43
EC - Ecuador 35
CO - Colombia 32
SA - Arabia Saudita 30
VE - Venezuela 27
PK - Pakistan 24
MA - Marocco 22
EG - Egitto 20
BE - Belgio 18
CL - Cile 16
KE - Kenya 16
UZ - Uzbekistan 16
PY - Paraguay 14
JO - Giordania 13
LT - Lituania 13
PH - Filippine 12
AZ - Azerbaigian 11
KZ - Kazakistan 11
NP - Nepal 11
PE - Perù 10
AE - Emirati Arabi Uniti 9
BO - Bolivia 9
NG - Nigeria 9
UY - Uruguay 9
AU - Australia 8
PT - Portogallo 8
AL - Albania 7
CH - Svizzera 7
CR - Costa Rica 7
DO - Repubblica Dominicana 7
DZ - Algeria 7
JM - Giamaica 7
PA - Panama 7
IL - Israele 6
IR - Iran 6
LB - Libano 6
MY - Malesia 6
SN - Senegal 6
ET - Etiopia 5
OM - Oman 5
PS - Palestinian Territory 5
RO - Romania 5
TH - Thailandia 5
TN - Tunisia 5
EU - Europa 4
GE - Georgia 4
LV - Lettonia 4
RS - Serbia 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
BB - Barbados 3
BG - Bulgaria 3
BY - Bielorussia 3
DK - Danimarca 3
GR - Grecia 3
GT - Guatemala 3
GY - Guiana 3
HR - Croazia 3
MD - Moldavia 3
BA - Bosnia-Erzegovina 2
BF - Burkina Faso 2
CG - Congo 2
CI - Costa d'Avorio 2
EE - Estonia 2
GD - Grenada 2
KW - Kuwait 2
LK - Sri Lanka 2
MU - Mauritius 2
NI - Nicaragua 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
Totale 20.120
Salva come PNG Salva come JPEG
Città #
Singapore 1.261
Ashburn 901
Fairfield 884
Hong Kong 688
Woodbridge 575
San Jose 436
Houston 400
Seattle 385
The Dalles 371
Cambridge 327
Beijing 320
Jacksonville 318
Wilmington 296
New York 274
Ann Arbor 262
Princeton 236
Los Angeles 232
Helsinki 205
Lauterbourg 193
Chandler 189
Istanbul 170
Milan 157
Ho Chi Minh City 154
Dublin 152
Munich 151
Chicago 121
Buffalo 113
Council Bluffs 107
Des Moines 100
São Paulo 100
Dearborn 97
Brescia 95
Dallas 95
Nanjing 94
Redondo Beach 88
Hanoi 86
Moscow 72
San Diego 72
London 62
Nuremberg 62
Santa Clara 58
Turku 57
San Francisco 56
Warsaw 53
Frankfurt am Main 51
Orem 51
Shenyang 50
Shanghai 49
Changsha 43
Salt Lake City 42
Rome 40
Nanchang 37
Guangzhou 34
Rio de Janeiro 34
Brno 33
Tokyo 33
Chennai 32
Montreal 32
Belo Horizonte 31
Atlanta 29
Lappeenranta 29
Boardman 28
Brooklyn 27
Jinan 26
Mexico City 26
Tampa 26
Tianjin 26
Vienna 26
Lancaster 25
Stockholm 25
Toronto 25
Johannesburg 24
Hangzhou 23
Ningbo 23
Brasília 22
Da Nang 22
Hebei 21
Romola 21
Denver 20
Olomouc 20
Elk Grove Village 19
Norwalk 19
Zhengzhou 19
Brussels 18
Dhaka 18
Phoenix 18
Poplar 18
Verona 18
Boston 17
Guarulhos 17
Düsseldorf 16
Kunming 16
Amsterdam 15
Kyiv 15
Porto Alegre 15
Quito 15
Charlotte 14
Manchester 14
Naples 14
Cape Town 13
Totale 12.559
Salva come PNG Salva come JPEG
Nome #
Plasma NfL, GFAP, amyloid, and p-tau species as Prognostic biomarkers in Parkinson’s disease 307
Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy 303
COVID-19 impact on consecutive neurological patients admitted to the emergency department 252
Altered brain metabolic connectivity at multiscale level in early Parkinson's disease 228
Mild Cognitive Impairment and Progression to Dementia in Progressive Supranuclear Palsy 223
Source-Based Morphometry Multivariate Approach to Analyze [123I]FP-CIT SPECT Imaging 207
Results from a pilot study on amiodarone administration in monogenic frontotemporal dementia with granulin mutation 196
Single-subject SPM FDG-PET patterns predict risk of dementia progression in Parkinson disease 192
Extrastriatal dopaminergic and serotonergic pathways in Parkinson’s disease and in dementia with Lewy bodies: a 123I-FP-CIT SPECT study 185
Stimulation over the cerebellum with a regular figure-of-eight coil induces reduced motor cortex inhibition in patients with progressive supranuclear palsy 184
Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases 181
Serum Non-Ceruloplasmin Non-Albumin Copper Elevation in Mild Cognitive Impairment and Dementia due to Alzheimer’s Disease: A Case Control Study 175
Application of the movement disorder society prodromal Parkinson's disease research criteria in 2 independent prospective cohorts 173
Validation and convergent validity of the Boston cognitive assessment (BOCA) in an Italian population: a comparative study with the Montreal cognitive assessment (MoCA) in Alzheimer's disease spectrum 171
The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design 170
Diagnosing Progressive Supranuclear Palsy: Role of Biological and Neuroimaging Markers 168
Understanding phenotype variability in frontotemporal lobar degeneration due to granulin mutation. 166
Voluptuary Habits and Risk of Frontotemporal Dementia: A Case Control Retrospective Study 166
Early stage of behavioral variant frontotemporal dementia: clinical and neuroimaging correlates. 165
Vascular risk factors and cognition in Parkinson's disease 160
Atypical presentation of a novel Presenilin 1 R377W mutation: sporadic, late-onset Alzheimer disease with epilepsy and frontotemporal atrophy. 159
Role of cytochrome P4502D6 functional polymorphisms in the efficacy of donepezil in patients with Alzheimer's disease 157
Association of Antidementia Drugs and Mortality in Community-Dwelling Frail Older Patients With Dementia: The Role of Mortality Risk Assessment 157
A Multidimensional Prognostic Index (MPI) based on a comprehensive geriatric assessment predicts short- and long-term all-cause mortality in older hospitalized patients with transient ischemic attack 156
Microarray gene and miRNA expression studies: Looking for new therapeutic targets for frontotemporal lobar degeneration 155
Association between cognitive impairment and urinary dysfunction in Parkinson’s disease 151
Clinical, biological, and imaging features of monogenic Alzheimer's Disease. 150
Three Decades of Comprehensive Geriatric Assessment: Evidence Coming From Different Healthcare Settings and Specific Clinical Conditions 147
Clinical presentation and outcomes of SARS-CoV-2 related encephalitis: the ENCOVID multicentre study 146
Effect of a CYP2D6 polymorphism on the efficacy of donepezil in patients with Alzheimer disease 142
Cerebrospinal fluid biogenic amines depletion and brain atrophy in adult patients with phenylketonuria 142
Reply to the Letter " Covid-19-associated encephalopathy and cytokine-mediated Neuroinflammation" 137
FOXP2, APOE, and PRNP: new modulators in primary progressive aphasia. 135
Warfarin Treatment and All-Cause Mortality in Community-Dwelling Older Adults with Atrial Fibrillation: A Retrospective Observational Study 135
Prospective longitudinal course of cognition in older subjects with mild parkinsonian signs 135
Overlap between frontotemporal dementia and alzheimer's disease: Cerebrospinal fluid pattern and neuroimaging study 133
Central serous chorioretinopathy: Pathogenesis and management 133
Metal Exposure and SNCA rs356219 Polymorphism Associated With Parkinson Disease and Parkinsonism 133
Verbal memory declines more in female patients with Parkinson's disease: The importance of gender-corrected normative data 132
Molecular signature of disease onset in granulin mutation carriers: a gene expression analysis study. 131
Functional genetic variation in the serotonin 5-HTTLPR modulates brain damage in frontotemporal dementia. 131
Cognitive impairment in Glucocerebrosidase (GBA)-associated PD: Not primarily associated with cerebrospinal fluid Abeta and Tau profiles 131
Role of the serotonin transporter gene locus in the response to SSRI treatment of major depressive disorder in late life. 130
GBA-associated parkinsonism and dementia: Beyond α-synucleinopathies? 130
TOMM40, APOE, and APOC1 in Primary Progressive Aphasia and Frontotemporal Dementia. 128
Autonomic dysfunction in subjects at high risk for Parkinson’s disease 127
Steroid-Responsive Encephalitis in Coronavirus Disease 2019 127
Erratum: Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases (Neuron (2016) 91(1) (56–66)(S0896627316301970)(10.1016/j.neuron.2016.05.018)) 124
Developments in the Role of Transcranial Sonography for the Differential Diagnosis of Parkinsonism 122
Pharmacogenetics of cytochrome P450 (CYP) in the elderly 122
Disease-modifying therapies in frontotemporal lobar degeneration. 121
Exploring Olfactory Function and Its Relation with Behavioral and Cognitive Impairment in Amyotrophic Lateral Sclerosis Patients: A Cross-Sectional Study. 121
In vivo markers of Parkinson’s disease and dementia with Lewy bodies: current value of the 5G4 α-synuclein antibody 121
Hypermetabolism in the cerebellum and brainstem and cortical hypometabolism are independently associated with cognitive impairment in Parkinson’s disease 121
Impulse control disorder in PD: A lateralized monoaminergic frontostriatal disconnection syndrome? 119
SARS-CoV-2 encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses 118
Autologous Stem Cell Transplantation before Lymphocyte Apheresis for CAR-T Cells Therapy Negatively Impacts on T-Cells Fitness and NK Cell Levels in DLBCL Patients 117
Co-infection of chlamydia pneumoniae and mycoplasma pneumoniae with SARS-CoV-2 is associated with more severe features 116
Pharmacological strategies for the management of levodopa-induced dyskinesia in patients with parkinson's disease 116
A 3D deep learning model to predict the diagnosis of dementia with Lewy bodies, Alzheimer’s disease, and mild cognitive impairment using brain 18F-FDG PET 115
Third ventricular width assessed by transcranial ultrasound correlates with cognitive performance in Parkinson's disease 114
Plasma neurofilament light chain predicts cognitive progression in prodromal and clinical dementia with lewy bodies 112
Plasma Cystatin C correlates with plasma NfL levels and predicts disease progression in Parkinson's disease 112
Brain glucose metabolism in Lewy body dementia: Implications for diagnostic criteria 111
Alterations of frontal-temporal gray matter volume associate with clinical measures of older adults with COVID-19 111
Metabolic patterns across core features in dementia with lewy bodies 110
Clinical Correlates of Functional Motor Disorders: An Italian Multicenter Study 109
Association of hippocampal subfields, CSF biomarkers and cognition in non-demented Parkinson's disease patients 109
Association of Orthostatic Hypotension With Cerebral Atrophy in Patients With Lewy Body Disorders 109
The p.Val234Met LRP10 likely pathogenic variant associated with Parkinson's disease: Possible molecular implications 108
Unveiling New Genetic Variants Associated with Age at Onset in Alzheimer's Disease and Frontotemporal Lobar Degeneration Due to C9orf72 Repeat Expansions 108
Brain-area specific white matter hyperintensities: Associations to falls in Parkinson's disease 108
Association of APOE genotype with blood-brain barrier permeability in neurodegenerative disorders 107
MicroRNA‑34a‑5p expression in the plasma and its extracellular vesicle fractions in subjects with Parkinson's disease: An exploratory study 107
Age and subtle cognitive impairment are associated with long-term olfactory dysfunction after COVID-19 infection 106
Long-term neurological manifestations of COVID-19: prevalence and predictive factors 105
NF-κB/c-Rel DNA-binding is reduced in substantia nigra and peripheral blood mononuclear cells of Parkinson's disease patients 104
Benign versus malignant Parkinson disease: the unexpected silver lining of motor complications 104
Imaging features and ultraearly hematoma growth in intracerebral hemorrhage associated with COVID-19 104
Dopaminergic deficits along the spectrum of Alzheimer’s disease 103
Impaired metabolic brain networks associated with neurotransmission systems in the α-synuclein spectrum 102
Plasma NfL, clinical subtypes and motor progression in Parkinson's disease 100
Clinical outcome of neurological patients with COVID-19: the impact of healthcare organization improvement between waves 100
Anterior EEG slowing in dementia with Lewy bodies: a multicenter European cohort study 99
Plasma levels of glial fibrillary acidic protein and neurofilament light chain in patients with chronic migraine: a multicenter case-control study 98
Struktureller Ultraschall des medialen Temporallappens bei Alzheimer-Demenz 98
Plasma p-tau181 and amyloid markers in Alzheimer's disease: A comparison between Lumipulse and SIMOA 97
Effects of COVID-19 outbreak on stroke admissions in Brescia, Lombardy, Italy 96
Accuracy of the clinical diagnosis of dementia with Lewy bodies (DLB) among the Italian Dementia Centers: a study by the Italian DLB study group (DLB-SINdem) 96
Long-term neurological outcome in patients presenting with encephalitis 95
Effects of dopaminergic treatment on inhibitory control differ across Hoehn and Yahr stages of Parkinson's disease 94
Differences Between Plasma and Cerebrospinal Fluid p-tau181 and p-tau231 in Early Alzheimer's Disease 94
A Bayesian approach to Essential Tremor plus: A preliminary analysis of the TITAN cohort 94
Occipital atrophy signature in prodromal Lewy bodies disease 93
Rivastigmine in Parkinson's Disease Dementia with Orthostatic Hypotension 93
Sex Differences in the Severity and Progression of Neuropsychiatric Symptoms Across Different Dementia Types 93
Neurological disorders throughout acute SARS-CoV2 infection: A comparative study between vaccinated and non-vaccinated patients 92
A multicentre validation study of the diagnostic value of plasma neurofilament light 91
Association of Plasma p-tau181 and p-tau231 Concentrations with Cognitive Decline in Patients with Probable Dementia with Lewy Bodies 88
Metabolic Correlates of Dopaminergic Loss in Dementia with Lewy Bodies 86
Totale 13.355
Salva come PNG Salva come JPEG
Categoria #
all - tutte 102.975
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 102.975
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021449 0 0 0 0 0 0 0 0 0 200 152 97
2021/2022992 98 120 36 54 35 57 45 76 58 90 83 240
2022/2023794 135 23 9 27 74 216 12 63 115 16 54 50
2023/20241.220 80 20 105 61 58 231 47 42 295 23 48 210
2024/20254.065 56 26 47 515 394 261 264 177 488 393 945 499
2025/20268.152 794 1.114 724 1.234 720 631 1.267 505 597 566 0 0
Totale 20.443